Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review
- 38 Downloads
Anal intraepithelial neoplasia (AIN) (or low/high grade squamous intraepithelial neoplasia (L/HSIL)) is the precursor of anal of early invasive anal cancer. Different treatment options for local ablation of localized lesions have been reported. The aim of this study was to analyze the clinical efficacy and safety of infrared coagulation for the treatment of anal dysplasia.
A search of the literature was performed in 2019 using PubMed and Cochrane to identify all eligible trials published reporting data on the treatment of anal dysplasia with infrared coagulation. The percentage of squamous cell carcinoma of the the anus that developed in the follow-up and results on major complications after treatment were the primary outcomes.
Twenty-four articles were identified from which 6 were selected with a total of 360 patients included, with a median age of 41.8 years. Three studies were prospective and 3 retrospective, only one was a randomized trial. All articles included males, 4 articles included HIV-positive women and only one article included non HIV infected males. No patient developed major complications after infrared coagulation therapy. Pain was the most common symptom found after the procedure in the different series and mild bleeding that did not require transfusion was the most common complication occurring in 4 to 78% of patients. Median follow-up was between 4.7 and 69 months. No patient developed squamous cell carcinoma after infrared treatment. Recurrent HSIL varied from 10 to 38%. Two studies reported results from follow-up of untreated patients showing that between 72 and 93% of them had persistent HSIL at last follow-up and 4.8% developed squamous cell carcinoma.
Infrared coagulation is a safe and effective method for ablation of high-grade anal dysplasia that could help prevent anal cancer. Continued surveillance is recommended due to the risk of recurrence.
KeywordsAnal dysplasia Infrared coagulation High resolution anoscopy Anal intraepithelial neoplasia
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
As this was a systematic review of existing studies ethical approval was not required.
For this type of study formal consent is not required.
- 1.Darragh TM, Colgan TJ, Cox JT, Members of LAST Project Work Groups et al (2012) The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 16:205–242CrossRefGoogle Scholar
- 4.Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD et al (2003) High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med [Internet]. American College of Physicians 138(6):453. https://doi.org/10.7326/0003-4819-138-6-200303180-00008
- 5.Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML (2008) High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum [Internet] 51(6):829–835 (discussion 835–7). https://insights.ovid.com/crossref?an=00003453-200851060-00003. Cited 1 Mar 2018
- 6.Scholefield JH, Ogunbiyi OA, Smith JH, Rogers K, Sharp F (1994) Treatment of anal intraepithelial neoplasia. Br J Surg [Internet] 81(8):1238–1240. http://www.ncbi.nlm.nih.gov/pubmed/7953374. Cited 1 Mar 2018
- 7.Scholefield JH (2004) Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum 46(11):1555–1559. Tech Coloproctol [Internet] 8(3):200. http://www.ncbi.nlm.nih.gov/pubmed/15654532. Cited 1 Mar 2018
- 8.Hamdan KA, Tait IS, Nadeau V, Padgett M, Carey F, Steele RJ (2003) Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum [Internet] 46(11):1555–1559. http://www.ncbi.nlm.nih.gov/pubmed/14605579. Cited 1 Mar 2018
- 9.Pehoushek J, Smith KJ (2001) Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol [Internet] 137(1):14–16. http://www.ncbi.nlm.nih.gov/pubmed/11176654. Cited 1 Mar 2018
- 10.Lyons M, Francis N, Allen-Mersh TG (1999) Treatment of grade 3 anal intraepithelial neoplasia by complete anal mucosal excision without fecal diversion: report of a case. Dis Colon Rectum [Internet] 42(10):1342–1344. http://www.ncbi.nlm.nih.gov/pubmed/10528776. Cited 1 Mar 2018
- 11.Goldstone SE, Kawalek AZ, Huyett JW (2005) Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum [Internet] 48(5):1042–1054. https://insights.ovid.com/crossref?an=00003453-200548050-00021. Cited 1 March 2018
- 14.Goldstone RN, Goldstone AB, Russ J, Goldstone SE (2011) Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum [Internet] 54(10):1284–1292. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003453-201110000-00013. Cited 1 Mar 2018
- 17.Goldstone SE, Lensing SY, Stier EA, Darragh T, Lee JY, van Zante A et al (2018) A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in HIV-infected adults: An AIDS Malignancy Consortium trial. Clin Infect Dis [Internet]. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciy615/5060387. Cited 21 Nov 2018
- 18.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol [Internet] 62:e1–34. http://www.jclinepi.com/article/S0895-4356(09)00180-2/pdf. Cited 1 Mar 2018
- 20.Dekkers OM, Egger M, Altman DG, Vandenbroucke JP (2012) Distinguishing case series from cohort studies. Ann Intern Med [Internet]. American College of Physicians 156(1_Part_1):37. http://annals.org/article.aspx?doi=10.7326/0003-4819-156-1-201201030-00006. Cited 1 Mar 2018
- 21.Cranston RD, Baker JR, Liu Y, Wang L, Elishaev E, Ho KS (2014) Topical application of trichloroacetic acid is efficacious for the treatment of internal anal high-grade squamous intraepithelial lesions in HIV-positive men. Sex Transm Dis [Internet] 41(7):420–426. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007435-201407000-00002. Cited 4 Apr 2018
- 22.Singh JC, Kuohung V, Palefsky JM, Iglesias D, Henostroza G, Seas C et al (2009) Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr [Internet] 52(4):474–479. https://insights.ovid.com/crossref?an=00126334-201002010-00009. Cited 4 Apr 2018
- 23.Marks DK, Goldstone SE (2012) Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men. J Acquir Immune Defic Syndr [Internet] 59(3):259–265. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00126334-201203010-00006. Cited 4 Apr 2018
- 24.Alemany L, Saunier M, Alvarado I, Quirós B, Salmeron J, Shin H et al (2015) HPV DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer [Internet] 1(1361):98–107. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270372/pdf/nihms644742.pdf. Cited 10 Mar 2018